Journal of Lipid Research, Vol 21, 277-283, Copyright © 1980 by Lipid Research, Inc.

ARTICLES

A deficiency of mixed function oxidase activities in the cholesterol biosynthetic pathway of human granulocytes

I Shechter, AM Fogelman and G Popjak

Highly purified human granulocytes synthesize [14C]farnesol and [14C]squalene but not [14C]sterols from [14C]mevalonic acid. Dimethylsulfoxide was found to be an excellent vehicle for carrying [3H]squalene-2, 3-oxide into the intact cells. The granulocytes synthesized [3H]lanosterol from this substrate, but were unable to further process the newly synthesized lanosterol along the cholesterol biosynthetic pathway. In contrast, intact lymphocytes and monocytes were able to synthesize radioactive cholesterol from either [14C]mevalonic acid or [3H]squalene-2,3-oxide. These results indicate that normal human granulocytes have retained squalene-2,3-oxide- lanosterol cyclase activity but have lost squalene epoxidase activity and at least one other mixed function oxidase activity that is required to transform lanosterol into cholesterol. These results may provide an explanation for the accumulation of farnesol and squalene that has been previously observed in populations of mixed leukocytes (Fogelman, A. M., Edmond, J., Seager, J., and Popjak, G. (1975) J. Biol. Chem. 250: 2045-2055 (1); Burns, C. P., Welshman, I. R., Edmond, J., and Spector A. A. (1979) Biochim. Biophys. Acta 572: 345-351) (12).
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Bonnans and B. D. Levy Lipid Mediators as Agonists for the Resolution of Acute Lung Inflammation and Injury Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 201 - 205. [Abstract] [Full Text] [PDF]

				B. D. Levy Myocardial 15-Epi-lipoxin A4 Generation Provides a New Mechanism for the Immunomodulatory Effects of Statins and Thiazolidinediones Circulation, August 29, 2006; 114(9): 873 - 875. [Full Text] [PDF]

				C. Bonnans, K. Fukunaga, R. Keledjian, N. A. Petasis, and B. D. Levy Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury J. Exp. Med., April 17, 2006; 203(4): 857 - 863. [Abstract] [Full Text] [PDF]

				K. Fukunaga, M. Arita, M. Takahashi, A. J. Morris, M. Pfeffer, and B. D. Levy Identification and Functional Characterization of a Presqualene Diphosphate Phosphatase J. Biol. Chem., April 7, 2006; 281(14): 9490 - 9497. [Abstract] [Full Text] [PDF]

				B. D. LEVY and C. N. SERHAN A Novel Polyisoprenyl Phosphate Signaling Cascade in Human Neutrophils Ann. N.Y. Acad. Sci., April 1, 2000; 905(1): 69 - 80. [Abstract] [Full Text] [PDF]

				B. D. LEVY, V. V. FOKIN, J. M. CLARK, M. J. O. WAKELAM, N. A. PETASIS, and C. N. SERHAN Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a `stop' signaling switch for aspirin-triggered lipoxin A4 FASEB J, May 1, 1999; 13(8): 903 - 911. [Abstract] [Full Text]